PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
19 hedge funds and large institutions have $530K invested in PLx Pharma Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 17 closing their positions.
41% less funds holding
Funds holding: 32 → 19 (-13)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
65% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 17
99% less capital invested
Capital invested by funds: $38.5M → $530K (-$38M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
+$104K |
| 2 |
MC
Middleton & Co
Boston,
Massachusetts
|
+$72.8K |
| 3 |
Bank of New York Mellon
New York
|
+$64.7K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$60.4K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$9.55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kingdon Capital Management
New York
|
-$13.7M |
| 2 |
TCP
Tourbillon Capital Partners
New York
|
-$3.45M |
| 3 |
6CM
683 Capital Management
New York
|
-$2.71M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$2.59M |
| 5 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$2.17M |
PLXP Hedge Fund Activity: Q4 2016 in Review
19 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q4 2016, worth a combined $530K — down 99% from $38.5M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of PLXP and 6 opened new positions — a net loss of 11 holders — while 7 trimmed existing stakes and 4 added.
The largest buyer was Acrospire Investment Management, opening a new position worth an estimated $104K. The largest seller was Kingdon Capital Management, exiting entirely with an estimated $13.7M sold.
- 19 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q4 2016, down from 32 in Q3 2016.
- Funds reported $530K of PLx Pharma Inc. Common Stock stock for Q4 2016, down 99% quarter-over-quarter.
- 6 funds opened new PLx Pharma Inc. Common Stock positions in Q4 2016 and 17 closed out, a net change of -11 holders.
- The largest PLx Pharma Inc. Common Stock buyer in Q4 2016 was Acrospire Investment Management, an estimated $104K added.
- The largest PLx Pharma Inc. Common Stock seller in Q4 2016 was Kingdon Capital Management, an estimated $13.7M sold.
Based on aggregated 13F filings for Q4 2016.